Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruin Moaddel

Showing results (151-160 of 217) with videos related to

Pageof 22
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 3, 2012
Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled studyLobna Ibrahim, Nancy Diazgranados, Jose Franco-Chaves, et al.
Aging Cell|July 12, 2018
Plasma proteomic signature of age in healthy humansToshiko Tanaka, Angelique Biancotto, Ruin Moaddel, et al.
Psychopharmacology|August 18, 2018
Plasma metabolomic profiling of a ketamine and placebo crossover trial of major depressive disorder and healthy control subjectsRuin Moaddel, Michelle Shardell, Mohammed Khadeer, et al.
Talanta|September 30, 2010
A parallel chiral-achiral liquid chromatographic method for the determination of the stereoisomers of ketamine and ketamine metabolites in the plasma and urine of patients with complex regional pain syndromeRuin Moaddel, Swarajya Lakshmi Vattem Venkata, Mary J Tanga, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 30, 2016
Effects of Ketamine and Ketamine Metabolites on Evoked Striatal Dopamine Release, Dopamine Receptors, and Monoamine TransportersAdem Can, Panos Zanos, Ruin Moaddel, et al.
Acta Neuropathologica|April 26, 2020
Biological sex and DNA repair deficiency drive Alzheimer's disease via systemic metabolic remodeling and brain mitochondrial dysfunctionTyler G Demarest, Vijay R Varma, Darlene Estrada, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 2019
(<i>2R,6R</i>)-hydroxynorketamine exerts mGlu<sub>2</sub> receptor-dependent antidepressant actionsPanos Zanos, Jaclyn N Highland, Brent W Stewart, et al.
Ebiomedicine|May 24, 2016
Child Stunting is Associated with Low Circulating Essential Amino AcidsRichard D Semba, Michelle Shardell, Fayrouz A Sakr Ashour, et al.
Aging Cell|February 6, 2019
Low plasma lysophosphatidylcholines are associated with impaired mitochondrial oxidative capacity in adults in the Baltimore Longitudinal Study of AgingRichard D Semba, Pingbo Zhang, Fatemeh Adelnia, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 8, 2020
Correction: Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depressionCristan A Farmer, Jessica R Gilbert, Ruin Moaddel, et al.
Pageof 22

Showing results (151-160 of 217) with videos related to

Sort By:
Pageof 22
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 3, 2012
Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled studyLobna Ibrahim, Nancy Diazgranados, Jose Franco-Chaves, et al.
Aging Cell|July 12, 2018
Plasma proteomic signature of age in healthy humansToshiko Tanaka, Angelique Biancotto, Ruin Moaddel, et al.
Psychopharmacology|August 18, 2018
Plasma metabolomic profiling of a ketamine and placebo crossover trial of major depressive disorder and healthy control subjectsRuin Moaddel, Michelle Shardell, Mohammed Khadeer, et al.
Talanta|September 30, 2010
A parallel chiral-achiral liquid chromatographic method for the determination of the stereoisomers of ketamine and ketamine metabolites in the plasma and urine of patients with complex regional pain syndromeRuin Moaddel, Swarajya Lakshmi Vattem Venkata, Mary J Tanga, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 30, 2016
Effects of Ketamine and Ketamine Metabolites on Evoked Striatal Dopamine Release, Dopamine Receptors, and Monoamine TransportersAdem Can, Panos Zanos, Ruin Moaddel, et al.
Acta Neuropathologica|April 26, 2020
Biological sex and DNA repair deficiency drive Alzheimer's disease via systemic metabolic remodeling and brain mitochondrial dysfunctionTyler G Demarest, Vijay R Varma, Darlene Estrada, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 2019
(<i>2R,6R</i>)-hydroxynorketamine exerts mGlu<sub>2</sub> receptor-dependent antidepressant actionsPanos Zanos, Jaclyn N Highland, Brent W Stewart, et al.
Ebiomedicine|May 24, 2016
Child Stunting is Associated with Low Circulating Essential Amino AcidsRichard D Semba, Michelle Shardell, Fayrouz A Sakr Ashour, et al.
Aging Cell|February 6, 2019
Low plasma lysophosphatidylcholines are associated with impaired mitochondrial oxidative capacity in adults in the Baltimore Longitudinal Study of AgingRichard D Semba, Pingbo Zhang, Fatemeh Adelnia, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 8, 2020
Correction: Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depressionCristan A Farmer, Jessica R Gilbert, Ruin Moaddel, et al.
Pageof 22